FDA Drug Application (076642) for REPREXAIN by AMNEAL PHARMS NY

Back to FDA Applications sponsored by AMNEAL PHARMS NY

Application Number076642
Product Number003
FormTABLET;ORAL
Dosage2.5MG;200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREPREXAIN
Active IngredientHYDROCODONE BITARTRATE; IBUPROFEN

Active IngredientCount
List of drugs with Active Ingredient HYDROCODONE BITARTRATE45
List of drugs with Active Ingredient IBUPROFEN51


Back to FDA Applications sponsored by AMNEAL PHARMS NY